Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Myocardial Reperfusion Injury 2Cardiotoxicity 2Vomiting 1Uveal Melanoma 1Thrombosis 1Substance Withdrawal Syndrome 1Retinal Diseases 1Reperfusion Injury 1Pain, Postoperative 1Opioid-Related Disorders 1Nausea 1Melanoma 1Macular Degeneration 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Choroid Diseases 1Breast Neoplasms 1

Interventions

Doxorubicin 15Exercise 9Cyclophosphamide 9Dexrazoxane 8Razoxane 6Carvedilol 6Vincristine 4Trastuzumab 4Radiotherapy 4Filgrastim 4Docetaxel 4Methotrexate 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Echocardiography 3Atorvastatin 3salicylhydroxamic acid 2sacubitril and valsartan sodium hydrate drug combination 2empagliflozin 2dapagliflozin 2Tablets 2Silymarin 2Prednisone 2Paclitaxel 2Neoadjuvant Therapy 2Leucovorin 2Ivabradine 2High-Intensity Interval Training 2Epirubicin 2Electrocardiography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cardiotoxicity × salicylhydroxamic acid × Clear all
NCT03166813 2022-06-08

Remote Ischaemic Preconditioning in Childhood Cancer

The University of Hong Kong

Phase NA Completed
68 enrolled

Neoplasms, Myocardial Reperfusion Injury, Cardiotoxicity

NCT02471885 2020-04-15

ERIC-ONC

University College, London

Phase NA Unknown
128 enrolled

Myocardial Reperfusion Injury, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡